UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia

J. B. Singer*, Y. Shou, F. Giles, H. M. Kantarjian, Y. Hsu, A. S. Robeva, P. Rae, A. Weitzman, J. M. Meyer, M. Dugan, O. G. Ottmann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

93 Scopus citations

Fingerprint Dive into the research topics of 'UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia'. Together they form a unique fingerprint.

Medicine & Life Sciences